絞り込み

16754

広告

Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.

著者 Catalá-López F , Macías Saint-Gerons D , González-Bermejo D , Rosano GM , Davis BR , Ridao M , Zaragoza A , Montero-Corominas D , Tobías A , de la Fuente-Honrubia C , Tabarés-Seisdedos R , Hutton B
PLoS Med.2016 Mar ; 13(3):e1001971.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (25view , 0users)

Full Text Sources

Medical

Miscellaneous

Medications aimed at inhibiting the renin-angiotensin system (RAS) have been used extensively for preventing cardiovascular and renal complications in patients with diabetes, but data that compare their clinical effectiveness are limited. We aimed to compare the effects of classes of RAS blockers on cardiovascular and renal outcomes in adults with diabetes.
PMID: 26954482 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード